| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Aug 7, 2025 | Aug 11, 2025 | Jazz Pharmaceuticals plc | Director | Sell | 95.0 | +1,702 | 18.63% | ✗ | $200.8K |
| Jul 2, 2025 | Jul 3, 2025 | Phreesia, Inc. | Director | Sell | 20.0 | -7,000 | -15.78% | ✓ | $203K |
| Aug 15, 2024 | Aug 19, 2024 | Teladoc Health, Inc. | Director | Buy | 91.3 | +4,000 | 91.85% | ✗ | $28.3K |
| Aug 2, 2024 | Aug 6, 2024 | Jazz Pharmaceuticals plc | Director | Sell | 95.0 | +2,247 | 32.62% | ✗ | $165.2K |
| Jul 18, 2024 | Jul 22, 2024 | Phreesia, Inc. | Director | Sell | 20.0 | -7,000 | -18.59% | ✓ | $175K |
| Dec 4, 2023 | Dec 6, 2023 | Jazz Pharmaceuticals plc | Director | Sell | 26.3 | -417 | -5.71% | ✗ | $49.7K |
| Aug 11, 2023 | Aug 15, 2023 | Jazz Pharmaceuticals plc | Director | Sell | 95.0 | +1,834 | 33.52% | ✗ | $171.5K |
| Apr 3, 2023 | Apr 5, 2023 | Phreesia, Inc. | Director | Sell | 10.0 | -7,000 | -30.29% | ✓ | $215.4K |
| Dec 2, 2022 | Dec 6, 2022 | Jazz Pharmaceuticals plc | Director | Sell | 22.5 | -420 | -7.13% | ✗ | $65K |
| Aug 5, 2022 | Aug 9, 2022 | Jazz Pharmaceuticals plc | Director | Sell | 95.0 | +1,472 | 33.31% | ✗ | $165.9K |
| Dec 2, 2021 | Dec 6, 2021 | Jazz Pharmaceuticals plc | Director | Sell | 22.5 | -417 | -8.62% | ✗ | $50.6K |
| Jan 4, 2021 | Jan 6, 2021 | Phreesia, Inc. | Director | Sell | 7.5 | -6,000 | -49.55% | ✓ | $315.4K |
| Aug 10, 2020 | Aug 12, 2020 | Phreesia, Inc. | Director | Sell | 10.0 | -6,000 | -49.55% | ✓ | $181.8K |